Search

Your search keyword '"Zappulo, E"' showing total 138 results

Search Constraints

Start Over You searched for: Author "Zappulo, E" Remove constraint Author: "Zappulo, E"
138 results on '"Zappulo, E"'

Search Results

1. Effect of Direct Antiviral Therapy Against HCV on CD4+ T Cell Count in Patients with HIV-HCV Coinfection

4. Sotrovimab in Solid Organ Transplant Patients With Early, Mild/Moderate SARS-CoV-2 Infection: A Single-center Experience

5. Clinical features and comorbidity pattern of HCV infected migrants compared to native patients in care in Italy: A real-life evaluation of the PITER cohort

6. Asunaprevir, a protease inhibitor for the treatment of hepatitis C infection

7. Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial

8. Clinical features of patients with home isolation SARS-COV-2 infection: A multicenter retrospective study in southern Italy

9. Pneumocystis jirovecii pneumonia in an immunocompetent patient recovered from COVID-19

10. Economic Consequences of Investing in Anti-HCV Antiviral Treatment from the Italian NHS Perspective: A Real-World-Based Analysis of PITER Data

11. Economic Consequences of Investing in Anti-HCV Antiviral Treatment from the Italian NHS Perspective: A Real-World-Based Analysis of PITER Data

12. Correction to: Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial (Journal of Translational Medicine, (2020), 18, 1, (405), 10.1186/s12967-020-02573-9)

13. Clinical features and comorbidity pattern of HCV infected migrants compared to native patients in care in Italy: A real-life evaluation of the PITER cohort

15. L'Italia come modello per l'Europa e per il mondo nelle politiche sanitarie per il trattamento dell'epatite cronica da HCV

18. Clinical characterization and economic impact evaluation of anti-HCV DAA treatment failure: real life data from the Italian Platform for the Study of Viral Hepatitis Therapies (PITER)

19. Diagnostic and therapeutic approaches of mixed cryoglobulinemia in PITER (Piattaforma Italiana per lo studio della Terapia delle Epatiti viRali) cohort

22. Response to measles-mumps-rubella vaccine in children with autism spectrum disorders

23. Exposure to varicella zoster virus is higher in children with autism spectrum disorder than in healthy controls. results from a case-control study

24. Prevalence of herpes simplex virus 1 and 2 antibodies in patients with autism spectrum disorders

25. Prevalence and titre of antibodies to cytomegalovirus and epstein-barr virus in patients with autism spectrum disorder

26. Clinical characterization and economic impact evaluation of anti-HCV DAA treatment failure: real life data fromthe Italian Platform for the Study of Viral Hepatitis Therapies (PITER)

27. Efficacy of the 'first wave' Direct Acting antivirals against HCV infection: Results from the Italian LINA (Liver Network Activity) cohort

28. Hepatitis C screening in the emergency department of a large hospital in Southern Italy: Results of a pilot study

29. Clinical features and comorbidity pattern of HCV infected migrants compared to native patients in care in Italy: A real-life evaluation of the PITER cohort

30. Incidence of DAA failure and the clinical impact of retreatment in real-life patients treated in the advanced stage of liver disease: Interim evaluations from the PITER network

31. Risk of invasive fungal infections among patients treated with disease modifying treatments for multiple sclerosis: a comprehensive review

32. Oral Vancomycin Prophylaxis for Primary and Secondary Prevention of Clostridioides difficile Infection in Patients Treated with Systemic Antibiotic Therapy: A Systematic Review, Meta-Analysis and Trial Sequential Analysis

33. Update on infective complications in patients treated with alemtuzumab for multiple sclerosis: review and meta-analysis of real-world and randomized studies

34. Case Report: Discovery a Novel SARS-CoV-2 Variant in a Six-Months Long-Term Swab Positive Female Suffering From Non-Hodgkin Lymphoma

35. Serum KL-6 Could Represent a Reliable Indicator of Unfavourable Outcome in Patients with COVID-19 Pneumonia

36. Diabetes and COVID-19: The potential role of mTOR

37. Novel strategies for the management of bacterial and fungal infections in patients with liver cirrhosis: focus on new antimicrobials

38. Efficacy and safety of a fixed dose combination tablet of asunaprevir + beclabuvir + daclatasvir for the treatment of Hepatitis C

39. Efficacy and safety of ceftolozane/tazobactam as therapeutic option for complicated skin and soft tissue infections by MDR/XDR Pseudomonas aeruginosa in patients with impaired renal function: a case series from a single-center experience

40. Risk of opportunistic infections in patients treated with alemtuzumab for multiple sclerosis

41. Incidence and predictive risk factors of infective events in patients with multiple sclerosis treated with agents targeting CD20 and CD52 surface antigens

42. Bacterial and CMV pneumonia in a patient treated with alemtuzumab for multiple sclerosis

43. Invasive pulmonary aspergillosis and pulmonary tuberculosis in a patient treated with infliximab for Crohn's disease

44. The role of curcumin in liver diseases

45. Real-world efficacy and safety of pangenotypic direct-acting antivirals against hepatitis C virus infection

46. Severe Vitamin D deficiency increases mortality among patients with liver cirrhosis regardless of the presence of HCC

47. Patologie virali tropicali (Flavivirus, Filovirus, Arenavirus, Bunyavirus, Togavirus: Chikungunya

48. Unsolved Issues in the Treatment of Spontaneous Peritonitis in Patients with Cirrhosis: Nosocomial Versus Community-acquired Infections and the Role of Fungi

49. Infezione da cytomegalovirus

50. HSV

Catalog

Books, media, physical & digital resources